Introduction
Galectin-1 (Gal-1) is a member of a family of β-galactoside binding lectins with specific affinity to terminal N-acetyl-lactosamine motifs on multi-antennary cell surface N-glycans. It is partially inhibited by terminal α-2-3, and fully inhibited by α-2,6-sialylation. Gal 
Materials and Methods
Blood samples from 14 active SLE, 9 inactive SLE, 13 RA and 11 SS patients as well as 16 healthy donors were collected. T-cells were stimulated with 1 μg/ml Phytohaemagglutinin for 72 h at 37 °C. -Gal-1 expressing MSCs induce T-cell apoptosis in in vitro co-culture system on a Gal-1 dependent fashion with identical mechanism as soluble Gal-1 does.
-Endogenous Gal-1 is not secreted from T-cells however it essentially contributes to extracellular Gal-1 induced apoptosis by an unknown mechanism.
-Activated SLE T-cells express lower amounts of Gal-1 mRNA pointing that intracellular Gal-1 can be a relevant factor in escaping extracellular Gal-1 mediated apoptosis.
-Cell surface glycosylation is altered in SLE T-cells including lower complexity of surface glycan chains and elevated sialylation, both changes inhibiting Gal-1 binding to T-cells. Hence defective apoptotic response of SLE may derive from pathological Gal-1 expression and glycosylation. T-cells from SS patients showed similar alterations while RA T-cells showed a shift to sialylation.
